EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging horizons of AI in pharmaceutical research

Sourav Bachhar, Suryasarathi Kumar, Basudeb Dutta, Somnath Das

Advances in Pharmacology · 2025

DOI: 10.1016/bs.apha.2025.01.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Pharmacology, 2025. Verfasst von Sourav Bachhar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electronics and Communication Engineering, Kalyani Government Engineering College, Nadia, West Bengal, India; The Institute of Science …. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Discovery, Pharmaceutical Research. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial Intelligence (AI) has revolutionized drug discovery by enhancing data collection, integration, and predictive modeling across various critical stages. It aggregates vast biological and chemical data, including genomic information, protein structures, and chemical interactions with biological targets. Machine learning techniques and QSAR models are applied by AI to predict compound behaviors and predict potential drug candidates. Docking simulations predict drug-protein interactions, while virtual screening eliminates large chemical databases through efficient sifting. Similarly, AI supports de novo drug design by generating novel molecules, optimized against a particular biological target, using generative models such as generative adversarial network (GAN), always finding lead compounds with the most desirable pharmacological properties. AI used in clinical trials improves efficiency by pinpointing responsive patient cohorts leveraging genetic profiles and biomarkers and maintaining propriety such as dataset diversity and compliance with regulations. This chapter aimed to summarize and analyze the mechanism of AI to accelerate drug discovery by streamlining different processes that enable informed decisions and bring potential life-saving therapies to market faster, amounting to a breakthrough in pharmaceutical research and development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDrug DiscoveryPharmaceutical ResearchHumansQuantitative Structure-Activity RelationshipAnimalsDrug DesignMachine Learning

Stichwörter der Autor:innen

Artificial intelligenceDeep learningDrug discoveryGANMachine learningNLPPharmaceutical industryQSAR

Autor:innen und Institutionen

  • Department of Electronics and Communication Engineering, Kalyani Government Engineering College, Nadia, West Bengal, India; The Institute of Science Culture and Social Studies, Belgharia, Kolkata, West Bengal, India.
  • The Institute of Science Culture and Social Studies, Belgharia, Kolkata, West Bengal, India; School of Biological Sciences & Technology, Department of Applied Biology, Maulana Abul Kalam Azad University of Technology, H…
  • Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku, Kyoto, Japan; Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, W…
  • Department of Chemistry, School of Applied Sciences, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha, India. Electronic address: chairman.tioscass@gmail.com.

Zitieren

APA

Bachhar, S., Kumar, S., Dutta, B., & Das, S. (2025). Emerging horizons of AI in pharmaceutical research. Advances in Pharmacology. https://doi.org/10.1016/bs.apha.2025.01.016

Vancouver

Bachhar S, Kumar S, Dutta B, Das S. Emerging horizons of AI in pharmaceutical research. Advances in Pharmacology. 2025. doi:10.1016/bs.apha.2025.01.016

BibTeX
@article{Bachhar2025,
  author = {Bachhar, Sourav and Kumar, Suryasarathi and Dutta, Basudeb and Das, Somnath},
  title = {Emerging horizons of AI in pharmaceutical research},
  journal = {Advances in Pharmacology},
  year = {2025},
  doi = {10.1016/bs.apha.2025.01.016}
}
Kostenlos starten →